
Robert Stockton Jones Jr.
Examiner (ID: 3854)
| Most Active Art Unit | 1762 |
| Art Unit(s) | 1796, 1762 |
| Total Applications | 1302 |
| Issued Applications | 945 |
| Pending Applications | 17 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4786340
[patent_doc_number] => 20080139669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Use of a blood-flow decrease preventing agent in conjunction with insufflating gas'
[patent_app_type] => utility
[patent_app_number] => 11/975136
[patent_app_country] => US
[patent_app_date] => 2007-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3304
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139669.pdf
[firstpage_image] =>[orig_patent_app_number] => 11975136
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/975136 | Use of a blood-flow decrease preventing agent in conjunction with insufflating gas | Oct 15, 2007 | Abandoned |
Array
(
[id] => 4922646
[patent_doc_number] => 20080070963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Compositions and methods for promoting neural regeneration'
[patent_app_type] => utility
[patent_app_number] => 11/900758
[patent_app_country] => US
[patent_app_date] => 2007-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16197
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070963.pdf
[firstpage_image] =>[orig_patent_app_number] => 11900758
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/900758 | Compositions and methods for promoting neural regeneration | Sep 12, 2007 | Abandoned |
Array
(
[id] => 6252547
[patent_doc_number] => 20100028457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'AGENT FOR PREVENTION OR TREATMENT OF BLOOD GLUCOSE LEVEL ELEVATION'
[patent_app_type] => utility
[patent_app_number] => 12/440140
[patent_app_country] => US
[patent_app_date] => 2007-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5681
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028457.pdf
[firstpage_image] =>[orig_patent_app_number] => 12440140
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/440140 | AGENT FOR PREVENTION OR TREATMENT OF BLOOD GLUCOSE LEVEL ELEVATION | Sep 5, 2007 | Abandoned |
Array
(
[id] => 4894054
[patent_doc_number] => 20080103153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE'
[patent_app_type] => utility
[patent_app_number] => 11/844476
[patent_app_country] => US
[patent_app_date] => 2007-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4228
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20080103153.pdf
[firstpage_image] =>[orig_patent_app_number] => 11844476
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/844476 | Combination of brimonidine and timolol for topical ophthalmic use | Aug 23, 2007 | Issued |
Array
(
[id] => 4909269
[patent_doc_number] => 20080020035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'Micronutrient formulations and related methods of manufacture'
[patent_app_type] => utility
[patent_app_number] => 11/893894
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5276
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20080020035.pdf
[firstpage_image] =>[orig_patent_app_number] => 11893894
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/893894 | Micronutrient formulations and related methods of manufacture | Aug 19, 2007 | Abandoned |
Array
(
[id] => 5085877
[patent_doc_number] => 20070275928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'METHOD OF TREATING METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETES'
[patent_app_type] => utility
[patent_app_number] => 11/781630
[patent_app_country] => US
[patent_app_date] => 2007-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18808
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275928.pdf
[firstpage_image] =>[orig_patent_app_number] => 11781630
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/781630 | METHOD OF TREATING METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETES | Jul 22, 2007 | Abandoned |
Array
(
[id] => 5085919
[patent_doc_number] => 20070275970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'COMPOSITIONS FOR AFFECTING WEIGHT LOSS'
[patent_app_type] => utility
[patent_app_number] => 11/779008
[patent_app_country] => US
[patent_app_date] => 2007-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14649
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275970.pdf
[firstpage_image] =>[orig_patent_app_number] => 11779008
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/779008 | COMPOSITIONS FOR AFFECTING WEIGHT LOSS | Jul 16, 2007 | Abandoned |
Array
(
[id] => 5027956
[patent_doc_number] => 20070269403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Composition and method for treatment of hepatic encephalopathy'
[patent_app_type] => utility
[patent_app_number] => 11/822445
[patent_app_country] => US
[patent_app_date] => 2007-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3134
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269403.pdf
[firstpage_image] =>[orig_patent_app_number] => 11822445
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/822445 | Composition and method for treatment of hepatic encephalopathy | Jul 5, 2007 | Abandoned |
Array
(
[id] => 4670428
[patent_doc_number] => 20080045488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'PREVENTION OF OVARIAN CANCER BY ADMINISTRATION OF PRODUCTS THAT INDUCE BIOLOGICAL EFFECTS IN THE OVARIAN EPITHELIUM'
[patent_app_type] => utility
[patent_app_number] => 11/771473
[patent_app_country] => US
[patent_app_date] => 2007-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39675
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20080045488.pdf
[firstpage_image] =>[orig_patent_app_number] => 11771473
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/771473 | PREVENTION OF OVARIAN CANCER BY ADMINISTRATION OF PRODUCTS THAT INDUCE BIOLOGICAL EFFECTS IN THE OVARIAN EPITHELIUM | Jun 28, 2007 | Abandoned |
Array
(
[id] => 5231410
[patent_doc_number] => 20070293518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'PROLONGED IMPROVEMENT OF RENAL FUNCTION COMPRISING INFREQUENT ADMINISTRATION OF AN AA1RA'
[patent_app_type] => utility
[patent_app_number] => 11/764018
[patent_app_country] => US
[patent_app_date] => 2007-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12840
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293518.pdf
[firstpage_image] =>[orig_patent_app_number] => 11764018
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/764018 | PROLONGED IMPROVEMENT OF RENAL FUNCTION COMPRISING INFREQUENT ADMINISTRATION OF AN AA1RA | Jun 14, 2007 | Abandoned |
Array
(
[id] => 5166154
[patent_doc_number] => 20070287741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-13
[patent_title] => 'COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING POSTOPERATIVE ILEUS AND GASTRIC STASIS IN MAMMALS'
[patent_app_type] => utility
[patent_app_number] => 11/761707
[patent_app_country] => US
[patent_app_date] => 2007-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5252
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20070287741.pdf
[firstpage_image] =>[orig_patent_app_number] => 11761707
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/761707 | COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING POSTOPERATIVE ILEUS AND GASTRIC STASIS IN MAMMALS | Jun 11, 2007 | Abandoned |
Array
(
[id] => 239636
[patent_doc_number] => 07592353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-22
[patent_title] => 'Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses'
[patent_app_type] => utility
[patent_app_number] => 11/755956
[patent_app_country] => US
[patent_app_date] => 2007-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11209
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/592/07592353.pdf
[firstpage_image] =>[orig_patent_app_number] => 11755956
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/755956 | Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses | May 30, 2007 | Issued |
Array
(
[id] => 4797899
[patent_doc_number] => 20080009485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Methods for the use of inhibitors of cytosolic phospholipase A2 in the treatment of thrombosis'
[patent_app_type] => utility
[patent_app_number] => 11/807341
[patent_app_country] => US
[patent_app_date] => 2007-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 72030
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20080009485.pdf
[firstpage_image] =>[orig_patent_app_number] => 11807341
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/807341 | Methods for the use of inhibitors of cytosolic phospholipase A2 in the treatment of thrombosis | May 24, 2007 | Abandoned |
Array
(
[id] => 4977944
[patent_doc_number] => 20070219177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'AGENT FOR TREATMENT OF CEREBRAL ISCHEMIC DISEASES'
[patent_app_type] => utility
[patent_app_number] => 11/753425
[patent_app_country] => US
[patent_app_date] => 2007-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3210
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219177.pdf
[firstpage_image] =>[orig_patent_app_number] => 11753425
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/753425 | Agent for treatment of cerebral ischemic diseases | May 23, 2007 | Issued |
Array
(
[id] => 4779551
[patent_doc_number] => 20080287549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'METHODS AND MATERIALS FOR CONTROLLING RODENT POPULATIONS'
[patent_app_type] => utility
[patent_app_number] => 11/750197
[patent_app_country] => US
[patent_app_date] => 2007-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4151
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287549.pdf
[firstpage_image] =>[orig_patent_app_number] => 11750197
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/750197 | METHODS AND MATERIALS FOR CONTROLLING RODENT POPULATIONS | May 16, 2007 | Abandoned |
Array
(
[id] => 92362
[patent_doc_number] => 07737185
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-15
[patent_title] => 'Methods and compositions with trans-clomiphene'
[patent_app_type] => utility
[patent_app_number] => 11/750190
[patent_app_country] => US
[patent_app_date] => 2007-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9848
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/737/07737185.pdf
[firstpage_image] =>[orig_patent_app_number] => 11750190
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/750190 | Methods and compositions with trans-clomiphene | May 16, 2007 | Issued |
Array
(
[id] => 5112557
[patent_doc_number] => 20070196472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'PHENYLEPHRINE TANNATE AND PYRILAMINE TANNATE SALTS IN PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/736629
[patent_app_country] => US
[patent_app_date] => 2007-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4673
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20070196472.pdf
[firstpage_image] =>[orig_patent_app_number] => 11736629
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/736629 | PHENYLEPHRINE TANNATE AND PYRILAMINE TANNATE SALTS IN PHARMACEUTICAL COMPOSITIONS | Apr 17, 2007 | Abandoned |
Array
(
[id] => 4939437
[patent_doc_number] => 20080076756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Use of paullone derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells'
[patent_app_type] => utility
[patent_app_number] => 11/786784
[patent_app_country] => US
[patent_app_date] => 2007-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3521
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076756.pdf
[firstpage_image] =>[orig_patent_app_number] => 11786784
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/786784 | Use of paullone derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells | Apr 11, 2007 | Issued |
Array
(
[id] => 4933534
[patent_doc_number] => 20080004309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/696549
[patent_app_country] => US
[patent_app_date] => 2007-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81303
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20080004309.pdf
[firstpage_image] =>[orig_patent_app_number] => 11696549
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/696549 | Pyrrolo- and Thiazolo-pyridine compounds, and methods of use thereof | Apr 3, 2007 | Issued |
Array
(
[id] => 341652
[patent_doc_number] => 07501410
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-10
[patent_title] => 'Methods of inhibiting BTK and SYK protein kinases'
[patent_app_type] => utility
[patent_app_number] => 11/725752
[patent_app_country] => US
[patent_app_date] => 2007-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51456
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/501/07501410.pdf
[firstpage_image] =>[orig_patent_app_number] => 11725752
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/725752 | Methods of inhibiting BTK and SYK protein kinases | Mar 19, 2007 | Issued |